Celleration’s MIST Therapy 5.0
This article was originally published in The Gray Sheet
Executive Summary
Diabetic foot ulcer treatment indication will be pursued by Celleration for the system by year-end, following a June 25 de novo 510(k) clearance for wound cleaning and debridement. The expanded indication submission will contain results from a recently completed 133-patient prospective, randomized double-blinded trial. MIST Therapy employs ultrasonic soundwaves to deliver a spray of sterile saline to the wound...